Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats

European Neuropsychopharmacology

Volumn 25, Issue 8, 2015, Pages 1362-1374

  Manduca, Antonia ^a   Morena, Maria ^b,c   Campolongo, Patrizia ^b   Servadio, Michela ^a   Palmery, Maura ^b   Trabace, Luigia ^d   Hill, Matthew N ^c   Vanderschuren, Louk J M J ^e,f   Cuomo, Vincenzo ^b   Trezza, Viviana ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF FOGGIA   (Italy)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Emotional behavior; Endocannabinoid system; Endocannabinoids; JZL195; Rodents; Social behavior

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; FATTY ACID AMIDASE INHIBITOR; JZL 195; RIMONABANT; UNCLASSIFIED DRUG; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR AFFECTING AGENT; CARBAMIC ACID DERIVATIVE; ENDOCANNABINOID; JZL195; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR ASSESSMENT; BEHAVIOR CHANGE; BRAIN FUNCTION; BRAIN LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG ANTAGONISM; DRUG EFFECT; ELEVATED PLUS MAZE TEST; EMOTIONALITY; ENZYME INHIBITION; HYDROLYSIS; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TASK PERFORMANCE; TRANQUILIZING ACTIVITY; AGING; ANIMAL; ANXIETY; BRAIN; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

AGING; ANIMALS; ANXIETY; ARACHIDONIC ACIDS; BRAIN; CANNABINOID RECEPTOR MODULATORS; CARBAMATES; ENDOCANNABINOIDS; EXPLORATORY BEHAVIOR; GLYCERIDES; MALE; PIPERAZINES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS, SPRAGUE-DAWLEY; SOCIAL BEHAVIOR;

EID: 84938742864     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.04.005     Document Type: Article

References (48)

1. Almeida-Santos A.F., Gobira P.H., Rosa L.C., Guimaraes F.S., Moreira F.A., Aguiar D.C. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. Behav. Brain Res. 2013, 252:10-17.
2. Bari M., Battista N., Fezza F., Gasperi V., Maccarrone M. New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev. Med. Chem. 2006, 6:257-268.
3. Berrendero F., Sepe N., Ramos J.A., Di Marzo V., Fernandez-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999, 33:181-191.
4. Blankman J.L., Simon G.M., Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 2007, 14:1347-1356.
5. Campolongo P., Trezza V., Ratano P., Palmery M., Cuomo V. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology 2011, 214:5-15.
6. Chang J.W., Niphakis M.J., Lum K.M., Cognetta A.B., Wang C., Matthews M.L., Niessen S., Buczynski M.W., Parsons L.H., Cravatt B.F. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates. Chem. Biol. 2012, 19:579-588.
7. Compton D.R., Gold L.H., Ward S.J., Balster R.L., Martin B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 1992, 263:1118-1126.
8. Di Marzo V., Cristino L. Why endocannabinoids are not all alike. Nat. Neurosci. 2008, 11:124-126.
9. Forman L.J. The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801. Brain Res. Bull. 2003, 61:153-158.
10. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18620-18625.
11. Hill M.N., Karacabeyli E.S., Gorzalka B.B. Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 2007, 32:350-357.
12. Jung K.M., Sepers M., Henstridge C.M., Lassalle O., Neuhofer D., Martin H., Ginger M., Frick A., DiPatrizio N.V., Mackie K., Katona I., Piomelli D., Manzoni O.J. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun. 2012, 3:1080.
13. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 2003, 9:76-81.
14. Kinsey S.G., O'Neal S.T., Long J.Z., Cravatt B.F., Lichtman A.H. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacol. Biochem. Behav. 2011, 98:21-27.
15. Lee T.T., Hill M.N., Hillard C.J., Gorzalka B.B. Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse 2013, 67:4-10.
16. Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E., Pavon F.J., Serrano A.M., Selley D.E., Parsons L.H., Lichtman A.H., Cravatt B.F. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 2009, 5:37-44.
17. Long J.Z., Nomura D.K., Vann R.E., Walentiny D.M., Booker L., Jin X., Burston J.J., Sim-Selley L.J., Lichtman A.H., Wiley J.L., Cravatt B.F. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20270-20275.
18. Lutz B. Endocannabinoid signals in the control of emotion. Curr. Opin. Pharmacol. 2009, 9:46-52.
19. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agro A., Cravatt B.F., Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat. Neurosci. 2008, 11:152-159.
20. Manduca A., Servadio M., Campolongo P., Palmery M., Trabace L., Vanderschuren L.J., Cuomo V., Trezza V. Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats. Eur. Neuropsychopharmacol. 2014, 24:1337-1348.
21. Marco E.M., Laviola G. The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. J. Psychopharmacol. 2011, 26:150-163.
22. Marco E.M., Rapino C., Caprioli A., Borsini F., Maccarrone M., Laviola G. Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system. Behav. Brain Res. 2011, 220:140-145.
23. Mechoulam R., Hanus L.O., Pertwee R., Howlett A.C. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat. Rev. Neurosci. 2014, 15:757-764.
24. Morena M., Campolongo P. The endocannabinoid system: an emotional buffer in the modulation of memory function. Neurobiol. Learn. Mem. 2014, 112:30-43.
25. Naidu P.S., Varvel S.A., Ahn K., Cravatt B.F., Martin B.R., Lichtman A.H. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology 2007, 192:61-70.
26. Niesink R.J., Van Ree J.M. Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats. Neuropharmacology 1989, 28:411-418.
27. Niphakis M.J., Cognetta A.B., Chang J.W., Buczynski M.W., Parsons L.H., Byrne F., Burston J.J., Chapman V., Cravatt B.F. Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. ACS Chem. Neurosci. 2013, 4:1322-1332.
28. Pellis S.M., Pellis V.C. Play-fighting differs from serious fighting in both target of attack and tactics of fighting in the laboratory rat Rattus norvegicus. Aggress. Behav. 1987, 13:227-242.
29. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 1986, 24:525-529.
30. Petrosino S., Di Marzo V. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr. Opin. Investig. Drugs 2010, 11:51-62.
31. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4:873-884.
32. Rademacher D.J., Hillard C.J. Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:633-641.
33. Realini N., Vigano D., Guidali C., Zamberletti E., Rubino T., Parolaro D. Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology 2011, 60:235-243.
34. Rubino T., Prini P., Piscitelli F., Zamberletti E., Trusel M., Melis M., Sagheddu C., Ligresti A., Tonini R., Di Marzo V., Parolaro D. Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol. Dis. 2014, 73C:60-69.
35. Sciolino N.R., Zhou W., Hohmann A.G. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacol. Res. 2011, 64:226-234.
36. Segatto M., Manduca A., Lecis C., Rosso P., Jozwiak A., Swiezewska E., Moreno S., Trezza V., Pallottini V. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats. Neuropsychopharmacology 2014, 39:841-854.
37. Seillier A., Dominguez Aguilar D., Giuffrida A. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. Pharmacol. Biochem. Behav. 2014, 124:153-159.
38. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
39. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215:89-97.
40. Trezza V., Baarendse P.J., Vanderschuren L.J. Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms. Neuropsychopharmacology 2009, 34:2560-2573.
41. Trezza V., Campolongo P., Manduca A., Morena M., Palmery M., Vanderschuren L.J., Cuomo V. Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. Front. Behav. Neurosci. 2012, 6:2.
42. Trezza V., Damsteegt R., Manduca A., Petrosino S., Van Kerkhof L.W., Pasterkamp R.J., Zhou Y., Campolongo P., Cuomo V., Di Marzo V., Vanderschuren L.J. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J. Neurosci. 2012, 32:14899-14908.
43. Trezza V., Vanderschuren L.J. Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology 2008, 197:217-227.
44. Trezza V., Vanderschuren L.J. Cannabinoid and opioid modulation of social play behavior in adolescent rats: differential behavioral mechanisms. Eur. Neuropsychopharmacol. 2008, 18:519-530.
45. Trezza V., Vanderschuren L.J. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats. J. Pharmacol. Exp. Ther. 2009, 328:343-350.
46. Vanderschuren L.J., Trezza V., Griffioen-Roose S., Schiepers O.J., Van Leeuwen N., De Vries T.J., Schoffelmeer A.N. Methylphenidate disrupts social play behavior in adolescent rats. Neuropsychopharmacology 2008, 33:2946-2956.
47. Wise L.E., Long K.A., Abdullah R.A., Long J.Z., Cravatt B.F., Lichtman A.H. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice. ACS Chem. Neurosci. 2012, 3:369-378.
48. Wotjak C.T. Role of endogenous cannabinoids in cognition and emotionality. Mini Rev. Med. Chem. 2005, 5:659-670.